←
OncLive.com121,173 posts
OncLive.com avatar✓

OncLive.com ✓

@OncLive

Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.

◷ Joined May 2009▧ 24,625 Photos and videos
OncLive.com avatar
OncLive.com@OncLive·19h

Responses to investigational rinatabart sesutecan (Rina-S) in platinum-resistant ovarian cancer were seen across all FRα expression levels, including undetectable. Elizabeth K. Lee, MD, reviews the phase 2 RAINFOL-01 data. Watch the OncLive® Rapid Readout: hubs.li/Q04Dm7q00 @EKLee_MD @DanaFarber #ovca #gyncsm #IGCS2026

0:24
OncLive.com avatar
OncLive.com@OncLive·Nov 16

🚨BREAKING @FDA News🚨 The FDA has approved giredestrant plus everolimus for the treatment of adult patients with ER–positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer that has recurred during or after endocrine-based adjuvant therapy, or has progressed on 1 or more endocrine-based regimens in the metastatic setting Full details ➡️: onclive.com/view/fda-approve… #bcsm #oncology

Post attachment